Please use this identifier to cite or link to this item:
|Title:||Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons|
|Citation:||Chee, J.L.Y., Guan, X.L., Lee, J.Y., Dong, B., Leong, S.M., Ong, E.H., Liou, A.K.F., Lim, T.M. (2005-01). Compensatory caspase activation in MPP+-induced cell death in dopaminergic neurons. Cellular and Molecular Life Sciences 62 (2) : 227-238. ScholarBank@NUS Repository. https://doi.org/10.1007/s00018-004-4413-4|
|Abstract:||Many have hypothesized that cell death in Parkinson's disease is via apoptosis and, specifically, by the mitochondrial-mediated apoptotic pathway. We tested this hypothesis using a mouse dopaminergic cell line of mesencephalic origin, MN9D, challenged with the Parkinsonism-causing neurotoxin MPP + (1-methyl-4-phenylpyridinium ion). Apoptosis was the main mode of cell death when the cells were subjected to MPP+ treatment under serum-free conditions for 24 h. Caspase-3 and caspase-9, however, were not activated, thus indicating the existence of alternate or compensatory cell death pathway(s) in dopaminergic neuronal cells. Using caspase inhibitors, we demonstrated that these pathways involve caspase-2, -8, -6 and -7. A time-course study indicated that activation of caspase-2 and -8 occurred up-stream of caspase-6 and caspase-7. Upon MPP+ challenge, the apoptosis-inducing factor was translocated from the mitochondria into the MN9D cytosol and nucleus. These results suggest the existence of alternative apoptotic pathways in dopaminergic neurons.|
|Source Title:||Cellular and Molecular Life Sciences|
|Appears in Collections:||Staff Publications|
Show full item record
Files in This Item:
There are no files associated with this item.
checked on Jul 14, 2018
WEB OF SCIENCETM
checked on Jul 4, 2018
checked on May 25, 2018
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.